Fosun Tourism’s post-Covid holiday fizzles
The resort unit of one of China’s leading conglomerates posted modest growth in the first quarter, as its broader outlook was clouded by debt issues at its parent Key Takeaways:…
Ximalaya aims high in third listing attempt
China’s leading podcast platform could become one of Hong Kong’s hottest tech offerings in recent years, boasting a huge base of loyal users and a recent move to profitability Key…
‘Warcraft’ return to NetEase signals extension of China’s gaming relaxation
A new deal to bring popular ‘World of Warcraft’ games back to China after a one-year absence will have relatively little financial impact on the game’s local host Key Takeaways:…
‘Sing! China’ flames out, leaving STAR CM in the dark
The popular talent reality show was temporarily suspended, and its creator’s revenue plunged, after a famous singer criticized it in a video last year Key Takeaways: STAR CM fell into…
Strawbear slips into the red but seeks salvation in AI
The drama production company has lost 90% of its market value since an IPO three years ago, and just posted its first annual loss Key Takeaways: Strawbear Entertainment made a…
Yalla seeks major game publishers for ‘Act Two’ of its hardcore gaming foray
The Middle Eastern social media and gaming company’s revenue rose 7.7% in the fourth quarter, as its profit soared nearly 80% on better monetization and cost controls Key Takeaways: Yalla’s…
Bar chain Helens tastes profits again after reboot
The Hong Kong-listed bar operator has found a way back to profit after launching a new franchise model last year Key Takeaways: Helens said it is on track to swing…
Recent Articles
RELATED ARTICLES
-
Fosun Tourism at crossroads as parent shops its two major assets
1992.HK 0656.HK -
Fosun Tourism embarks on new journey with departure of big-name director
1992.HK
-
Fosun Tourism rides Club Med rebound into bumper profits
1992.HK
-
Debt pressures cast cloud over Fosun Pharma results
2196.HK 600196.SHG
- CHINA BULLETIN: Next Stop, Deflation
-
Tongcheng flies high on post-Covid domestic travel boom
0780.HK
-
Fosun Pharma, CanSino take different paths as Covid lift fade
2196.HK 6185.HK
